VTVT
VTVT
NASDAQ · Biotechnology

Vtv Therapeutics Inc- Cl A

$30.12
-0.40 (-1.31%)
As of Sep 29, 2:50 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +11.4% upside
Low Target $24.17
Average Target $33.56
High Target $46.23
Current Price $30.12
Current
$30.12
Target
$33.56
$24.17 $33.56 avg $46.23
Scenario Analysis
Bear Case
$24.17
-19.8%
Low target
Base Case
$33.56
+11.4%
Avg target
Bull Case
$46.23
+53.5%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$44.00
-31.5% from high
52-Week Low
$19.50
+54.5% from low
Target vs 52W High
$33.56
-23.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%